Opko Health Inc (OPK)

[tomsylver]

OPKO Renal ASN Kidney Week 2014 Detailed Data On Rayaldee

Charles Bishop - Chief Executive Officer, OPKO Renal Division
Over the past quarter, we have continued manufacturing large quantities of Alpharen tablets in preparation for the planned near-term start of a final Phase 3 trial needed for marketing approval in both the United States and Europe. Lastly, we secured a late-breaking clinical presentation spot at next week’s meeting of the American Society of Nephrology ( https://www.asn-online.org/ ) on Saturday, November 15. We will present more detailed data on Rayaldee then.

The American Society of Nephrology (ASN) ( https://www.asn-online.org/ ) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.

Kidney Week Abstracts

Kidney Week 2014 Abstracts

* Program Builder Site ( https://www.asn-online.org/education/kidneyweek/2014/program-builder.aspx )
* Abstract Supplement (PDF, 30.4MB) ( https://www.asn-online.org/api/download/?file=/education/kidneyweek/archives/KW14Abstracts.pdf )

ASN Kidney Week 2014 Philadelphia, PA Nov 11-16
Saturday, November 15, 2014 Oral Abstract Session

High-Impact Clinical Trials
Hall D
Moderators:
Michel Chonchol, MD, and T. Alp Ikizler, MD, FASN

SA-PO1103 Safety and Efficacy of Modified-Release Calcifediol for Secondary Hyperparathyroidism in Patients with Stage 3 or 4 CKD and Vitamin D Insufficiency — Stuart M. Sprague ( https://www.asn-online.org/ajax/disclosure.aspx?ID=16296&ajax=true ) , Shaukat Ali, Roberto Mangoo-Karim, Paul W. Crawford, Pablo E. Pergola, Laurel Sindelar, Stephen A Strugnell, Joel Z. Melnick, Jay A. White, Martin P. Petkovich, Charles W. Bishop ( http://www.opkorenal.com/about_us/management/bishop.html ) . Chicago, IL.